Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Intellectual Property
February 11, 2019
Life Sciences and Healthcare
February 7, 2019
Life Sciences and Healthcare
February 1, 2019